Trials / Conditions / Immunoglobulin A (IgA) Nephropathy
Immunoglobulin A (IgA) Nephropathy
3 registered clinical trials studyying Immunoglobulin A (IgA) Nephropathy — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | PS-002 for the Treatment of IgA Nephropathy in Adults NCT07182227 | Purespring Therapeutics Limited | Phase 1 / Phase 2 |
| Recruiting | Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis NCT07219121 | Travere Therapeutics, Inc. | Phase 4 |
| Completed | Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephr NCT05065970 | HI-Bio, A Biogen Company | Phase 2 |